E-LIB Suche - Ergebnisse für: Forster, M.D.

1

VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizum..:

Metcalf, R. ; Laban, S. ; Kristensen, C.A....
Annals of Oncology. 35 (2024) 8 - p. 754-755 , 2024

Link: https://doi.org/10.1016/..

2

11MO Final data from a phase II study (TACTI-002) of eftila..:

Majem, M. ; Forster, M.D. ; Krebs, M.G....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S43-S44 , 2023

Link: https://doi.org/10.1016/..

3

Adverse childhood experiences and alcohol related negative ..:

Forster, M. ; Rogers, C.J. ; Tinoco, S....
Addictive Behaviors. 136 (2023) - p. 107484 , 2023

Link: https://doi.org/10.1016/..

4

Comparing in-person, blended and virtual training intervent..:

Kiguli-Malwadde, E. ; Forster, M. ; Eliaz, A....
PLOS Global Public Health. 3 (2023) 7 - p. e0001654 , 2023

Link: https://doi.org/10.1371/..

5

40 Patient-reported outcomes from the CodeBreaK 200 phase I..:

Waterhouse, D.M. ; Rothschild, S. ; Dooms, C....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S37-S38 , 2023

Link: https://doi.org/10.1016/..

6

Development and validation of a risk score (Delay-7) to pre..:

Chambers, P. ; Forster, M.D. ; Patel, A....
ESMO Open. 8 (2023) 1 - p. 100743 , 2023

Link: https://doi.org/10.1016/..

7

271P Impact of COVID-19 vaccination on health-related quali..:

Forster, M. ; Würstlein, R. ; Koenig, A....
ESMO Open. 8 (2023) 1 - p. 101367 , 2023

Link: https://doi.org/10.1016/..

8

Light ion dynamics in the topside ionosphere and plasmasphe..:

Pakhotin, I. P. ; Burchill, J. K. ; Förster, M..
Earth, Planets and Space. 75 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

9

MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in ..:

Middleton, G. ; Fletcher, P. ; Savage, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S119-S120 , 2023

Link: https://doi.org/10.1016/..

10

EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel A..:

Horne, A. ; Brown, S. ; Butterworth, K....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S267-S268 , 2022

Link: https://doi.org/10.1016/..

11

EP08.01-109 TACTI-002: A Phase II Study of Eftilagimod Alph..:

Forster, M. ; Krebs, M. ; Majem, M....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S395 , 2022

Link: https://doi.org/10.1016/..

12

Mesenchymal Stem/Stromal Cells: ANALYSIS OF PATIENT PERIPHE..:

Graham, R. ; Kolluri, K. ; Davies, A....
Cytotherapy. 24 (2022) 5 - p. S48-S49 , 2022

Link: https://doi.org/10.1016/..

13

S107: SOD2 PROMOTES ACUTE LEUKEMIA ADAPTATION TO AMINO ACID..:

Ibrahim, N. K. ; Schreek, S. ; Cinar, B....
HemaSphere. 6 (2022) - p. 8-9 , 2022

Link: https://doi.org/10.1097/..

14

179P Early proof of concept of safety and clinical activity..:

Forster, M.D. ; Cave, J. ; Greystoke, A....
Immuno-Oncology and Technology. 16 (2022) - p. 100291 , 2022

Link: https://doi.org/10.1016/..

15

OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in..:

Sacher, A. ; Patel, M.R. ; Miller Jr., W.H....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S8-S9 , 2022

Link: https://doi.org/10.1016/..